Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

Europe - EBR:MELE - BE0165385973 - Common Stock

66.9 EUR
+2.7 (+4.21%)
Last: 9/18/2025, 1:19:05 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to MELE. MELE was compared to 56 industry peers in the Semiconductors & Semiconductor Equipment industry. MELE scores excellent points on both the profitability and health parts. This is a solid base for a good stock. MELE is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

MELE had positive earnings in the past year.
In the past year MELE had a positive cash flow from operations.
In the past 5 years MELE has always been profitable.
Each year in the past 5 years MELE had a positive operating cash flow.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

MELE has a Return On Assets of 14.74%. This is amongst the best in the industry. MELE outperforms 80.36% of its industry peers.
MELE has a better Return On Equity (23.23%) than 73.21% of its industry peers.
With a decent Return On Invested Capital value of 16.46%, MELE is doing good in the industry, outperforming 76.79% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for MELE is significantly above the industry average of 14.85%.
The last Return On Invested Capital (16.46%) for MELE is well below the 3 year average (31.03%), which needs to be investigated, but indicates that MELE had better years and this may not be a problem.
Industry RankSector Rank
ROA 14.74%
ROE 23.23%
ROIC 16.46%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

Looking at the Profit Margin, with a value of 15.42%, MELE is in line with its industry, outperforming 57.14% of the companies in the same industry.
In the last couple of years the Profit Margin of MELE has grown nicely.
MELE's Operating Margin of 18.29% is in line compared to the rest of the industry. MELE outperforms 58.93% of its industry peers.
In the last couple of years the Operating Margin of MELE has grown nicely.
The Gross Margin of MELE (40.24%) is worse than 62.50% of its industry peers.
In the last couple of years the Gross Margin of MELE has grown nicely.
Industry RankSector Rank
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MELE is creating value.
Compared to 1 year ago, MELE has about the same amount of shares outstanding.
Compared to 5 years ago, MELE has more shares outstanding
MELE has a worse debt/assets ratio than last year.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 7.69 indicates that MELE is not in any danger for bankruptcy at the moment.
MELE has a Altman-Z score of 7.69. This is in the better half of the industry: MELE outperforms 60.71% of its industry peers.
The Debt to FCF ratio of MELE is 2.40, which is a good value as it means it would take MELE, 2.40 years of fcf income to pay off all of its debts.
MELE's Debt to FCF ratio of 2.40 is in line compared to the rest of the industry. MELE outperforms 57.14% of its industry peers.
MELE has a Debt/Equity ratio of 0.38. This is a healthy value indicating a solid balance between debt and equity.
MELE's Debt to Equity ratio of 0.38 is on the low side compared to the rest of the industry. MELE is outperformed by 67.86% of its industry peers.
Even though the debt/equity ratio score it not favorable for MELE, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 2.4
Altman-Z 7.69
ROIC/WACC1.56
WACC10.52%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

A Current Ratio of 4.54 indicates that MELE has no problem at all paying its short term obligations.
MELE has a Current ratio of 4.54. This is amongst the best in the industry. MELE outperforms 85.71% of its industry peers.
A Quick Ratio of 2.01 indicates that MELE has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.01, MELE is doing good in the industry, outperforming 73.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.54
Quick Ratio 2.01
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

MELE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -36.82%.
MELE shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.04% yearly.
MELE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.33%.
MELE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.89% yearly.
EPS 1Y (TTM)-36.82%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-22.31%
Revenue 1Y (TTM)-13.33%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.89%

3.2 Future

The Earnings Per Share is expected to grow by 10.13% on average over the next years. This is quite good.
Based on estimates for the next years, MELE will show a small growth in Revenue. The Revenue will grow by 5.23% on average per year.
EPS Next Y-28.82%
EPS Next 2Y-2.97%
EPS Next 3Y4.96%
EPS Next 5Y10.13%
Revenue Next Year-10.64%
Revenue Next 2Y-0.52%
Revenue Next 3Y3.18%
Revenue Next 5Y5.23%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.52, the valuation of MELE can be described as rather expensive.
Based on the Price/Earnings ratio, MELE is valued a bit cheaper than 73.21% of the companies in the same industry.
MELE is valuated rather cheaply when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
MELE is valuated correctly with a Price/Forward Earnings ratio of 16.80.
78.57% of the companies in the same industry are more expensive than MELE, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.70. MELE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 20.52
Fwd PE 16.8
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MELE.
78.57% of the companies in the same industry are more expensive than MELE, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 29.24
EV/EBITDA 13.43
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

The decent profitability rating of MELE may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.89
EPS Next 2Y-2.97%
EPS Next 3Y4.96%

5

5. Dividend

5.1 Amount

MELE has a Yearly Dividend Yield of 3.88%. Purely for dividend investing, there may be better candidates out there.
MELE's Dividend Yield is rather good when compared to the industry average which is at 1.29. MELE pays more dividend than 100.00% of the companies in the same industry.
MELE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 3.88%

5.2 History

On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

112.64% of the earnings are spent on dividend by MELE. This is not a sustainable payout ratio.
MELE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP112.64%
EPS Next 2Y-2.97%
EPS Next 3Y4.96%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (9/18/2025, 1:19:05 PM)

66.9

+2.7 (+4.21%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29
Inst Owners15.6%
Inst Owner ChangeN/A
Ins Owners25.01%
Ins Owner ChangeN/A
Market Cap2.70B
Analysts77.78
Price Target76.73 (14.69%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.88%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP112.64%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.96%
Min EPS beat(2)-2.47%
Max EPS beat(2)42.38%
EPS beat(4)1
Avg EPS beat(4)-0.06%
Min EPS beat(4)-38.45%
Max EPS beat(4)42.38%
EPS beat(8)3
Avg EPS beat(8)-0.67%
EPS beat(12)6
Avg EPS beat(12)0.27%
EPS beat(16)10
Avg EPS beat(16)4.23%
Revenue beat(2)1
Avg Revenue beat(2)0.71%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)3.28%
Revenue beat(4)1
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.74%
Revenue beat(12)3
Avg Revenue beat(12)-1.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.6%
PT rev (1m)1.22%
PT rev (3m)18.13%
EPS NQ rev (1m)-1.93%
EPS NQ rev (3m)-20.85%
EPS NY rev (1m)-4.3%
EPS NY rev (3m)-4.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.03%
Revenue NY rev (1m)0.9%
Revenue NY rev (3m)1.05%
Valuation
Industry RankSector Rank
PE 20.52
Fwd PE 16.8
P/S 3.16
P/FCF 29.24
P/OCF 20.5
P/B 4.76
P/tB 4.77
EV/EBITDA 13.43
EPS(TTM)3.26
EY4.87%
EPS(NY)3.98
Fwd EY5.95%
FCF(TTM)2.29
FCFY3.42%
OCF(TTM)3.26
OCFY4.88%
SpS21.17
BVpS14.05
TBVpS14.02
PEG (NY)N/A
PEG (5Y)0.89
Profitability
Industry RankSector Rank
ROA 14.74%
ROE 23.23%
ROCE 19.8%
ROIC 16.46%
ROICexc 17.17%
ROICexgc 17.2%
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
FCFM 10.81%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexcg growth 3Y-14.81%
ROICexcg growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score4
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0.38
Debt/FCF 2.4
Debt/EBITDA 1.03
Cap/Depr 77.5%
Cap/Sales 4.61%
Interest Coverage 14.77
Cash Conversion 63.61%
Profit Quality 70.12%
Current Ratio 4.54
Quick Ratio 2.01
Altman-Z 7.69
F-Score4
WACC10.52%
ROIC/WACC1.56
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-36.82%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-22.31%
EPS Next Y-28.82%
EPS Next 2Y-2.97%
EPS Next 3Y4.96%
EPS Next 5Y10.13%
Revenue 1Y (TTM)-13.33%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.89%
Revenue Next Year-10.64%
Revenue Next 2Y-0.52%
Revenue Next 3Y3.18%
Revenue Next 5Y5.23%
EBIT growth 1Y-40.01%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-15.16%
EBIT Next 3Y8.75%
EBIT Next 5Y7.78%
FCF growth 1Y533.34%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y213.78%
OCF growth 3Y7.8%
OCF growth 5Y13.55%